SEATTLE, WA, Feb. 7, 2012 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive Officer, will be presenting at the following upcoming investment conferences in February.
| 14th Annual BIO CEO & Investor Conference Tuesday, February 14, 2012 at 2:30 p.m. Eastern time in New York, NY | |||||
| Citi 2012 Global Health Care Conference Tuesday, February 28, 2012 at 4:30 p.m. Eastern time in New York, NY |
A live and archived webcast of each presentation will be accessible by visiting the Oncothyreon website www.oncothyreon.com under the “News & Events” section.
In addition, Dr. Kirkman will participate in a panel at the 2012 RBC Capital Markets Global Healthcare Conference on Wednesday, February 29, 2012 at 11 a.m. Eastern time in New York, NY. The panel is titled “The Future of Immunotherapy Key Phase III Trials to Watch.”
About Oncothyreon
Oncothyreon is a biotechnology company specializing in the development of innovative therapeutic products for the treatment of cancer. Oncothyreon’s goal is to develop and commercialize novel synthetic vaccines and targeted small molecules that have the potential to improve the lives and outcomes of cancer patients. For more information, visit www.oncothyreon.com.
ONCOTHYREON INC., 2601 Fourth Avenue, Suite 500, Seattle, WA 98121
Tel: (206) 801-2100 Fax: (206) 801-2101
http://www.oncothyreon.com
SOURCE Oncothyreon Inc.
